Boards & Committees - Standards and Guidelines
PROFESSIONAL STANDARDS AND GUIDELINES COMMITTEE COMMITTEE LEADERSHIP:COMMITTEE CHAIR:
April 2015, Nice, France (date/time TBA)
As part of our mission, ISHLT engages in the regular development of guidelines, consensus documents, standards statements, and policy statements regarding end-stage heart disease, end-stage lung disease, heart transplantation, and lung transplantation. A complete list of these documents that ISHLT has published, co-authored, and/or endorsed is listed below, organized by date of publication. Free access to the full text of most of the below documents is available by clicking on the titles.
This is the document which all ISHLT-developed standards and guidelines are required to follow.
Visit the Guidelines
page to see the published ISHLT Guidelines, Standards Statements, Policy Statements, Consensus Documents since 1998.
- The leader of each Scientific Council Professional Standards and Guidelines Workforce shall serve on the Committee.
- The Committee Chair may appoint up to three at large committee members to serve one-year, renewable terms for the purpose of ensuring broad geographic representation on the Committee.
- Identify the need to update existing standards and guidelines and to develop new standards and guidelines relevant to the mission of the Society.
- Develop a calendar for the regular review/revision of existing standards and guidelines and for the development of new standards and guidelines.
- Develop criteria to which all ISHLT standards and guidelines documents must adhere, to include the following: content and format standards; endorsement/adoption of standards and guidelines developed by other organizations; development of standards and guidelines jointly with other organizations; rights of publication of co-sponsored standards and guidelines.
- Develop policies regarding content development of standards and guidelines, to include the following: authorship and content must reflect the international nature of the Society and the broad interests of the membership; evidence based medicine approaches must be systematically incorporated; minority and special populations must be considered; all guidelines must be developed into pocket guideline and a downloadable slide set.
- Review proposal for standards and guidelines generated by the Scientific Councils.
- Refer proposals for standards and guidelines to the appropriate Scientific Council Standards and Guidelines Workforce for development into formal proposals.
- Act as liaison between the Scientific Council Standards and Guidelines Workforces, the proposed guideline authors, and the Board to facilitate presentation of well structured proposals for the board's consideration, with appropriate budget proposals.
- Act as liaison with the Journal editor to keep him/her aware of timelines, topics and length of proposed standards and guidelines documents to facilitate appropriate and timely publication strategies.
- Coordinate with the Communications Committee regarding external distribution/public awareness of ISHLT guidelines and the publication of guidelines in other-language journals.
- Coordinate with the Education Committee regarding the development of educational activities to disseminate information/training about new standards and quidelines.
- Provide initial review of requests from other organizations to co-sponsor or endorse guidelines relevant to the mission of the society and make recommendations to the Board regarding such.
University of Wisconsin
Madison, WI, USA
firstname.lastname@example.orgMaryl R. Johnson, MD, received her medical degree from the University of Iowa College of Medicine where she also completed postgraduate training in Internal Medicine and Cardiovascular Diseases. She joined the faculty at Iowa and was instrumental in the establishment of a cardiac transplant program, serving as the Medical Director of Cardiac Transplantation from 1984-1988. Her subsequent career has been entirely devoted to the care of patients with heart failure and following cardiac transplantation. She served as the Associate Medical Director of the Cardiac Transplant Program at Loyola University Medical Center from 1988-1994, Associate Medical Director of the Rush Heart Failure and Cardiac Transplant Program from 1994-1997, and Medical Director, Heart Failure and Transplantation at Northwestern Memorial Hospital from 1998-2002. She moved to the University of Wisconsin as Medical Director of Heart Failure and Transplantation and Professor of Medicine in July 2002. Dr. Johnson's clinical interests are in the care of patients with severe congestive heart failure, including the use of mechanical circulatory support devices and cardiac transplantation. She has a particular interest in the treatment and outcome of congestive heart failure in women. Her research interests include the use of mechanical assistance in patients with severe heart failure and the coronary artery disease which develops in cardiac transplant recipients. She has also been an investigator in many of the multicenter trials evaluating new agents for the medical treatment of heart failure.COMMITTEE PAST CHAIR:
University of Alabama at Birmingham
Birminham, Alabama, USA
email@example.comJames Kirklin, MD, is a Professor and Director of the Division of Cardiothoracic Surgery at the University of Alabama School of Medicine in Birmingham. Dr. Kirklin is a 1973 graduate of Harvard Medical School. He completed his residency at Massachusetts General Hospital and the University of Toronto, and completed two fellowships at Children's Hospital, Boston and the University of Alabama at Birmingham. He is a past president of the ISHLT and former editor-in-chief of the Journal for Heart and Lung Transplantation. COUNCIL WORKFORCE LEADERS:
University of Alberta
Edmonton, Alberta, CANADA
firstname.lastname@example.orgBio coming soon...
Ohio State University Medical Center
Columbus, Ohio, USA
email@example.comStanley Martin, MD, is an Assistant Professor in the Division of Internal Medicine at The Ohio State University Medical Center. Dr. Martin has a clinical and research interest in infectious diseases related to non-HIV immunocompromised hosts. His work and training have focused mainly on patients undergoing solid organ and bone marrow transplantation. His research interests have included molecular virology in transplantation, xenotransplantation, and infectious complications of monoclonal antibody therapy. Dr. Martin earned his MD at the University of Tennessee and subsequently completed his internship and residency in Internal Medicine at the Mayo Clinic in Rochester, MN. He went on to complete an infectious diseases fellowship at Massachusetts General Hospital in Boston, MA.
Minneapolis Heart Institute
Minneapolis, Minnesota, USA
612-863-3980Feldman.firstname.lastname@example.orgDavid S. Feldman, MD, PhD, FACC, FAHA, is a researcher and clinical cardiologist at the Minneapolis Heart Institute Foundation in Minneapolis, Minnesota. His interests include heart and lung transplantation. Dr. Feldman is also Director of Heart Failure, VAD and Cardiac Transplantation at the Minneapolis Heart Institute at Abbott Northwestern Hospital. Dr. Feldman received his medical training at the Medical College of Georgia in Atlanta. He completed his residency and a Medicine and Cardiology fellowship at Washington University School of Medicine in St. Louis, and a Molecular and Cell Biology fellowship at Duke University Medical Center in Durham, North Carolina.
Annemarie Kaan, MCN, RN
St. Paul's Hospital
Vancouver, BC, CANADA
email@example.comAnnemarie Kaan is Clinical Nurse Specialist in heart failure/transplant at St Paul's Hospital in Vancouver, Canada, and an Adjunct Professor with University of British Columbia School of Nursing. She holds a Masters degree in Clinical Nursing. With over 25 years experience in cardiac nursing in Australia and Canada, Ms. Kaan is an international leader in acute heart failure VAD and transplant nursing.
Rochester, MN, USA
firstname.lastname@example.orgJoseph J. Maleszewski, M.D. is an Associate Professor of Pathology and Medicine at Mayo Clinic College of Medicine and Consultant in the Divisions of Anatomic Pathology, Cardiovascular Diseases, Medical Genetics, and Biochemistry and Immunology at Mayo Clinic. After graduating from Michigan State University's College of Human Medicine, he completed his residency in Anatomic and Clinical Pathology at the Johns Hopkins Hospital and, subsequently, fellowships in Cardiovascular Pathology and Molecular Genetic Pathology at Mayo Clinic. Dr. Maleszewski's clinical and research interests include diagnostic cardiovascular pathology, congenital heart disease, cardiac and pulmonary transplantation, and pulmonary vascular disease.
The Prince Charles Hospital
61-7-3350-8111Peter_Hopkins@health.qld.gov.auDr Peter Hopkins is the Director of the Quensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. Executive positions are held with the Australian Lung Foundation (PIVOT and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and National Examiners Panel Royal Australian College of Physicians.